PRISM MEDICO AND PHARMACY LTD. - 512217 - Closure of Trading Window
Dear Sir/Madam, Pursuant to Code of Conduct to regulate, monitor and report Trading by Insiders ("Code") and applicable SEBI Regulations, we would like to inform you that trading window for dealing in securities of the company by insiders stands closed from January 01, 2024 and will be reopened 48 hours after the declaration of the financial results for the quarter ended December 31, 2023 to the Stock Exchange. PRISM MEDICO AND PHARMACY LTD. - 512217 - Clarification sought from Prism Medico and Pharmacy Ltd
The Exchange has sought clarification from Prism Medico and Pharmacy Ltd on December 22, 2023 with reference to significant movement in price, in order to ensure that investors have latest relevant information about the company and to inform the market so that the interest of the investors is safeguarded.The reply is awaited. PRISM MEDICO AND PHARMACY LTD. - 512217 - Revision In Outcome Of Board Meeting Held On 08Th November, 2023.
Dear Sir/Madam, With reference to the captioned subject, please find the attached revised outcome of Board Meeting. You are requested to kindly take the same on record and oblige. Thanking You. PRISM MEDICO AND PHARMACY LTD. - 512217 - Details Of Related Party Transactions (RPT'S) As Per Regulation 23(9) Of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015.
Dear Sir/Madam, Pursuant to Regulation 23(9) of SEBI (LODR) Regulations, 2015 please find enclosed herewith details of related party transactions for the half year ended 30th September, 2023. You are requested to kindly take the same on record and oblige. Thanking You. PRISM MEDICO AND PHARMACY LTD. - 512217 - Board Meeting Outcome for Outcome Of The Board Meeting - Disclosure Under Regulation 30 Of The Securities Exchange Board Of India (Listing Obligations And Disclosure Requirements) Regulations, 2015.
Dear Sir/Madam, Pursuant to Regulation 30 of the Securities Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, we are pleased to inform you that the Board of Directors of the company at their meeting held today (i.e. 08th November, 2023) which commenced at 04:00 P.M. and concluded at 05:30 P.M. have inter alia approved the following: ? The Board considered and approved the Unaudited Standalone Financial Results of the company for the quarter and half year ended 30th September, 2023 alongwith the Limited Review Report duly signed by the Auditors of the company. You are requested to kindly take the same on record and oblige. Thanking You. PRISM MEDICO AND PHARMACY LTD. - 512217 - Board Meeting Intimation for Regulation 29(1) Of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015.
PRISM MEDICO AND PHARMACY LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 08/11/2023 ,inter alia, to consider and approve Dear Sir/Madam, With reference to the captioned subject and in compliance with Regulation 29 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we wish to inform that the meeting of the Board of Directors of M/s. Prism Medico and Pharmacy Limited (hereinafter referred as 'the Company') is scheduled to be held at the registered office of the company i.e. Suketi Road, Kala Amb, Sirmaur, Himachal Pradesh-173030 on Wednesday, the 08th day of November, 2023 at 04:00 P.M. inter alia, to: - Consider, approve and take on record the Unaudited Standalone Financial Results of the company along with the Limited Review Report for the quarter and half year ended 30th September, 2023, as per Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. - Consider and discuss any other routine matter or business of the company. You are requested to kindly take the same on your record and acknowledge receipt. Thanking You. PRISM MEDICO AND PHARMACY LTD. - 512217 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
Dear Sir/Madam, Please find attached herewith copy of compliance certificate issued by the RTA for the quarter ended 30th September, 2023 pursuant to Regulation 74(5) of SEBI (Depositories and Participants) Regulations, 2018. Thanking You. PRISM MEDICO AND PHARMACY LTD. - 512217 - Intimation Under Regulation 57(4) Of SEBI (Listing Obligations And Disclosure Requirements), Regulations, 2015.
Dear Sir/Madam, Please find the attached intimation under Regulation 57(4) of SEBI (LODR) Regulations, 2015. Thanking You. PRISM MEDICO AND PHARMACY LTD. - 512217 - Investor Complaints As Per Regulation 13(3) Of The SEBI (Listing Obligation And Disclosure Requirements) Regulations, 2015.
Dear Sir/Madam, Please find the attached statement of investment complaints as per Regulation 13(3) of SEBI (LODR) Regulations, 2015. Thanking You. PRISM MEDICO AND PHARMACY LTD. - 512217 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
Dear Sir/Madam, Please find attached herewith copy of compliance certificate issued by RTA for the quarter ended 30th September, 2023 pursuant to Regulation 74(5) of SEBI (LODR) Regulations, 2015. Thanking You.